All In MedTech

Device Trial Radar · NCT07928674

Prehospital mSOFA-Kit Decision Support for the Detection of Multiple Organ Failure

Design, Construction and Clinical Validation of the mSOFA-Kit: Integrated Device for the Detection of Prehospital Multiple Organ Failure. A Cluster-Randomized Clinical Trial

Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 3,780 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

3,780

Planned (sponsor's estimate)

Start

Apr 1, 2027

Primary completion

Oct 31, 2029

Study completion Dec 31, 2029

Sponsor

Lead sponsor
University of ValladolidAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Instituto de Salud Carlos III; Gerencia Regional de Salud de Castilla y Leon
First posted
Nov 10, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Health services research
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn whether the mSOFA-Kit, a decision support system that calculates the modified Sequential Organ Failure Assessment (mSOFA) score on scene, improves the outcomes of adults attended by Advanced Life Support Units (USVA) for a potentially critical condition. The main question it aims to answer is: does systematic on-scene stratification of multiorgan risk with the mSOFA-Kit reduce the 2-day composite adverse outcome (all-cause mortality, in-hospital cardiac arrest, admission to a level 2 or 3 ICU, invasive mechanical ventilation or renal replacement therapy) compared with the standard XABCDE assessment? Researchers will compare USVAs using the mSOFA-Kit with a visible score (intervention arm) with USVAs applying standard XABCDE care with a blinded mSOFA score (control arm). Ambulance units, not individual patients, are randomly assigned to each arm. In both arms, a small venous blood sample, obtained from the peripheral venous catheter already placed for clinical care, is analyzed on scene with a point-of-care analyzer. Participants will: * receive the usual prehospital care of their emergency service; * have their on-scene data and their hospital outcomes recorded; * be followed up to 90 days through medical records and death registries.

Conditions

  • Multiple Organ Failure
  • Critical Illness

Interventions

  • mSOFA-KitDevice

    Decision support system whose core is the mSOFA-App (Software as a Medical Device, Class IIb). From a venous point-of-care blood test (epoc NXS analyzer) and the vital signs of the USVA monitor, it automatically calculates the mSOFA score (0-17), stratifies the patient into 5 risk levels and displays protocol-based recommendations; it also supports structured pre-alert to the receiving hospital.

  • Standard XABCDE assessmentOther

    Standard prehospital care protocol (eXsanguination, Airway, Breathing, Circulation, Disability, Exposure) of each emergency medical service, with the point-of-care blood test available to the professional but without calculation or display of the mSOFA score.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite adverse outcome at 2 daysTime frame: 48 hours (+/- 6 hours) after hospital admission

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Gerencia de Emergencias Sanitarias de Castilla y León

    Valladolid, Castille and León, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.